Clari Vest Asset Management LLC Kodiak Sciences Inc. Transaction History

Clari Vest Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$7.09 - $89.45 $44,298 - $558,883	-6,248 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $33,229 - $52,809	-411 Reduced 6.17%	6,248 $529,000
Q3 2021 Nov 08, 2021	SELL	$81.97 - $106.94 $18,935 - $24,703	-231 Reduced 3.35%	6,659 $638,000
Q2 2021 Aug 09, 2021	BUY	$77.2 - $126.54 $1,389 - $2,277	18 Added 0.26%	6,890 $641,000
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $44,180 - $65,788	-400 Reduced 5.5%	6,872 $779,000
Q4 2020 Feb 09, 2021	SELL	$60.78 - $154.03 $597,285 - $1.51 Million	-9,827 Reduced 57.47%	7,272 $1.07 Million
Q3 2020 Nov 09, 2020	BUY	$45.05 - $59.27 $263,542 - $346,729	5,850 Added 52.0%	17,099 $1.01 Million
Q2 2020 Aug 12, 2020	SELL	$42.74 - $66.25 $216,178 - $335,092	-5,058 Reduced 31.02%	11,249 $609,000
Q1 2020 May 04, 2020	SELL	$38.18 - $73.95 $2,596 - $5,028	-68 Reduced 0.42%	16,307 $778,000
Q4 2019 Feb 12, 2020	BUY	$13.9 - $76.65 $227,612 - $1.26 Million	16,375 New	16,375 $1.18 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $433M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.